🔴 Biomea Fusion is trading 5.74% down in pre-market — No clear negative company-specific catalyst identified

Biomea Fusion is trading 5.74% down at $1.80 in pre-market, based on the provided quote; no clear negative company-specific catalyst was identified for September 4, 2026.

• The latest located announcement was routine participation in investor conferences scheduled for September 10 and September 15, not earnings, financing, or a major clinical update.
• Broader markets were mixed-to-slightly positive, so macro sentiment does not clearly explain the decline.